Micron Technology Inc. (NASDAQ:MU)

The valuation metrics demonstrate significant volatility and cyclicality, characterized by a period of compression in profit-based multiples followed by an aggressive expansion in asset and revenue-based multiples toward the end of the observed period.

Profitability-Based Valuation (P/E and P/OP)

The Price to Earnings (P/E) and Price to Operating Profit (P/OP) ratios exhibit a mirrored trajectory, reflecting the cyclical nature of earnings. Both ratios experienced a sharp decline between 2020 and mid-2022, reaching cyclical lows of 5.97 for P/E and 5.31 for P/OP in June 2022. A period of extreme volatility followed, highlighted by a substantial spike in August 2024, where the P/E ratio reached 145.72 and the P/OP ratio reached 86.94. By the final quarters of 2025 and 2026, these ratios stabilized, with P/E settling between 20.78 and 27.16, suggesting a return to more sustainable valuation levels relative to earnings.

Revenue-Based Valuation (P/S)

The Price to Sales (P/S) ratio remained relatively constrained between 1.83 and 4.41 from December 2020 through December 2022. A moderate upward trend was observed through mid-2024, followed by a brief correction. However, starting in February 2025, a steep acceleration occurred, with the ratio climbing from 3.38 to 15.18 by May 2026. This indicates a dramatic increase in the market's willingness to pay a premium for the company's top-line revenue.

Asset-Based Valuation (P/BV)

The Price to Book Value (P/BV) ratio reflects a similar pattern to the P/S ratio. After reaching a minimum of 1.09 in December 2022, the ratio trended upward, peaking momentarily at 3.32 in May 2024 before a temporary decline. A rapid and significant expansion began in early 2025, with the P/BV ratio rising from 2.18 in February 2025 to 13.61 by May 2026. This suggests a substantial increase in the valuation of the company's equity relative to its book value.

Overall, the divergence between the stabilizing profit ratios (P/E, P/OP) and the aggressively expanding asset and revenue ratios (P/S, P/BV) in the 2025-2026 period suggests a shift in market sentiment, where valuation is driven more by growth expectations and asset premiums than by current trailing profitability.

The analysis of the equity valuation reveals a cyclical pattern characterized by three distinct phases: a period of valuation compression, a phase of earnings contraction leading to negative multiples, and a subsequent period of exponential growth and valuation stabilization.

Valuation Compression (December 2020 – September 2022)

During this interval, a divergence between earnings and share price is observed. While earnings per share (EPS) grew steadily from 2.68 to a peak of 8.99 in June 2022, the price-to-earnings (P/E) ratio experienced a significant contraction, falling from 28.88 to a low of 5.97. This indicates that the market's valuation multiple decreased even as the company's profitability improved.

Earnings Contraction and Valuation Gap (December 2022 – May 2024)

A sharp decline in profitability is evident starting in early 2023, with EPS turning negative in June 2023 and reaching a trough of -6.23 in November 2023. Consequently, the P/E ratio became mathematically undefined for several quarters. Despite the negative earnings, the share price began a recovery trend starting in late 2023, suggesting that market sentiment began to price in a future recovery ahead of actual financial results.

Exponential Recovery and Multiple Stabilization (August 2024 – May 2026)

The return to positive earnings in August 2024 triggered a brief period of extreme P/E volatility, with the ratio spiking to 145.72 due to a low initial EPS of 0.70. As earnings growth accelerated aggressively—reaching 44.69 by May 2026—the P/E ratio stabilized within a tight range between 20.78 and 27.16. The final period shows a strong positive correlation between share price and EPS, with the share price increasing from 102.25 to 1,213.56, while the valuation multiple remained relatively constant.

Overall, the data demonstrates a transition from a low-multiple environment to a high-growth regime. The most recent trend indicates that the market has assigned a consistent valuation multiple to the company, with share price appreciation being driven primarily by explosive growth in earnings per share rather than expansion of the P/E ratio.

The valuation trajectory of the common stock exhibits three distinct phases characterized by a shift from valuation compression to operational distress and, ultimately, an aggressive expansion of both price and earnings.

Valuation Compression Phase (December 2020 – December 2022)

During this period, the Price to operating profit (P/OP) ratio experienced a consistent downward trend, falling from 25.85 to 7.86. This compression was primarily driven by a significant increase in operating profit per share, which grew from 3.00 to a peak of 10.09 in June 2022. The decline in the P/OP ratio indicates that operating profit growth outpaced the growth in share price, resulting in a lower valuation multiple relative to operational performance.

Operational Downturn and Valuation Volatility (March 2023 – May 2024)

A period of severe operational contraction is observed starting in March 2023, with operating profit per share turning negative and reaching a trough of -6.04 in November 2023. This operational deficit rendered the P/OP ratio largely inapplicable or unavailable for several quarters. A brief spike in the P/OP ratio to 34.54 in March 2023 preceded the transition into negative profitability, reflecting a disconnect between market pricing and declining operational yields.

Exponential Expansion Phase (August 2024 – May 2026)

The final phase is marked by a rapid and simultaneous increase in both share price and operating profit per share. While the share price rose exponentially from 87.09 in November 2024 to 1,213.56 by May 2026, the operating profit per share also grew substantially, reaching 52.46. Consequently, the P/OP ratio stabilized within a relatively tight corridor between 17.11 and 23.13. This suggests that the massive increase in market valuation was fundamentally supported by an equally aggressive scaling of operating profits.

Overall, the analysis reveals a cyclical pattern where the stock shifted from being undervalued relative to peak profits in 2022, through a period of operational loss, to a high-growth state where valuation and profitability expanded in tandem.

The price-to-sales (P/S) ratio exhibits significant volatility over the analyzed period, transitioning from a phase of valuation compression to a period of extreme expansion.

Valuation Contraction (2021–2022)

A downward trend in the P/S ratio is observed from June 2021 through December 2022. The ratio reached a trough of 1.83 in June 2022. This contraction occurred even as sales per share peaked at 29.36 during the same month, indicating that the market valuation decreased despite an increase in revenue generation per share.

Recovery and Mid-term Correction (2023–2024)

A recovery phase commenced in March 2023, with the P/S ratio expanding to a peak of 6.86 by May 2024. This increase reflects a period where the share price grew more rapidly than sales per share. However, a correction followed in the latter half of 2024, with the ratio declining to 3.34 by November 2024, suggesting a temporary stabilization or market realignment.

Exponential Expansion (2025–2026)

The final period is characterized by an aggressive surge in the valuation multiple. From May 2025 to May 2026, the P/S ratio escalated from 4.17 to 15.18. This trajectory was driven by a disproportionate increase in share price, which rose from 126.00 to 1,213.56, far outpacing the growth in sales per share, which moved from 30.21 to 79.93. This indicates a shift toward a significantly higher valuation premium relative to revenue.

The valuation of the company exhibits three distinct phases over the analyzed period, characterized by an initial contraction, a moderate recovery, and a subsequent phase of exponential growth in the price-to-book value (P/BV) ratio.

Valuation Contraction (2020-2022)

Between December 2020 and December 2022, a general downward trend in the P/BV ratio is observed, falling from 2.17 to a period low of 1.09. This decline was primarily driven by a significant reduction in share price, which decreased from a high of 95.65 in December 2021 to 49.43 by December 2022. This occurred despite a simultaneous increase in the book value per share (BVPS), which rose from 35.67 to 45.19 during the same window, compressing the ratio as the market price converged toward the accounting value.

Recovery and Stabilization (2023-2024)

A recovery phase began in early 2023, with the P/BV ratio ascending from 1.47 in March 2023 to a peak of 3.32 in May 2024. During this interval, the share price rebounded strongly, reaching 132.23. The BVPS exhibited relative stability or slight volatility, fluctuating between 38.85 and 40.70, indicating that the expansion in the P/BV ratio during this period was almost exclusively driven by market price appreciation rather than growth in net assets.

Exponential Valuation Expansion (2025-2026)

The final period is marked by a dramatic acceleration in both share price and the P/BV ratio. From May 2025 onward, the P/BV ratio surged from 2.78 to 13.61 by May 2026. While the book value per share also grew significantly, rising from 45.35 to 89.18, the growth in share price was disproportionately aggressive, culminating in a price of 1,213.56. This shift represents a transition to a high-premium valuation, where the market price vastly exceeds the underlying book value.